Author:
Cowan Alan,Liu-Chen Lee-Yuan,Inan Saadet
Funder
National Institutes of Health
National Institute on Drug Abuse
Subject
Pharmacology (medical),Drug Discovery,Pharmacology
Reference42 articles.
1. Itching, chloroquine, and malaria: a review of recent molecular and neuroscience advances and their contribution to mechanistic understanding and therapeutics of chronic non-histaminergic pruritus;Ajani;International Journal of Dermatology,2019
2. Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands;Ansonoff;Psychopharmacology (Berl),2010
3. Role of mu, but not delta or kappa, opioid receptors in context-induced reinstatement of oxycodone seeking;Bossert;European Journal of Neuroscience,2019
4. Brust TF, Morgenweck J, Kim SA, Rose JH, Locke JL, Schmid CL, Zhou L, Stahl EL, Cameron MD, Scarry SM, Aubé J, Jones SR, Martin TJ, Bohn LM. Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria. Science Signaling 2017; 9(456): ra117. doi:10.1126/scisignal.aai8441.
5. Impact of pharmacological manipulation of the κ-opioid receptor system on self-grooming and anhedonic-like behaviors in male mice;Butelman;Journal of Pharmacology and Experimental Therapeutics,2019